Z-1317-2015 Class II Terminated
FDA device recall Z-1317-2015 was initiated by Becton Dickinson & Company on Feb 19, 2015 and is designated Class II. Reason for recall: Becton Dickinson received an elevated number of complaints for blood or infusate/medication leakage due to tearing of the silicone septum. The recall status is terminated (terminated May 25, 2017). Affected quantity: 315,800 units.
Recall details
- Product Type
- Devices
- Report Date
- Apr 1, 2015
- Initiation Date
- Feb 19, 2015
- Termination Date
- May 25, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 315,800 units
Product description
BD Q-Syte Luer Access Split Septum, 0.16 ml, Sterile, Rx only, Catalog REF #385100, Manufacturer: Becton Dickinson Infusion Therapy Systems Inc. An accessory to an intravascular administration set that permits injection, gravity flow or withdrawal of fluids.
Reason for recall
Becton Dickinson received an elevated number of complaints for blood or infusate/medication leakage due to tearing of the silicone septum.
Distribution pattern
Distributed to the states of CA, CT, FL, IL, MA, ND, NY, OH and PA.
Code information
Lot #'s 4128925 and 4128926
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1317-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026